Endothelin-A Receptor Antagonist–Mediated Vasodilatation Is Attenuated by Inhibition of Nitric Oxide Synthesis and by Endothelin-B Receptor Blockade
- 3 March 1998
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 97 (8) , 752-756
- https://doi.org/10.1161/01.cir.97.8.752
Abstract
Background—The role of endothelin (ET)-1 in maintenance of basal vascular tone has been demonstrated by local and systemic vasodilatation to endothelin receptor antagonists in humans. Although the ...Keywords
This publication has 28 references indexed in Scilit:
- California dreamin' 'bout endothelin: emerging new therapeuticsTrends in Pharmacological Sciences, 1996
- The Clinical Potential of Endothelin Receptor Antagonists in Cardiovascular MedicineDrugs, 1996
- Up-Regulation of Endothelin-B Receptors in Atherosclerotic Human Coronary ArteriesJournal of Cardiovascular Pharmacology, 1996
- The Pharmacology of Human Blood Vessels in vivoJournal of Vascular Research, 1995
- Is endothelin-induced vasoconstriction mediated only by ETA receptors in humans?Trends in Pharmacological Sciences, 1994
- Growth regulatory properties of endothelinsPeptides, 1993
- Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptorLife Sciences, 1992
- Phosphoramidon inhibits the generation of endothelin-1 from exogenously applied big endothelin-1 in cultured vascular endothelial cells and smooth muscle cellsFEBS Letters, 1991
- Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptorNature, 1990
- Cloning and expression of a cDNA encoding an endothelin receptorNature, 1990